
chromosome 22 with a small part of that chromosome missing; and
WHEREAS, The 22q11.2 deletion is most often not inherited
from either parent and does not usually run in families; and
WHEREAS, If the condition is suspected, a blood test to
detect the deletion can be performed; and
WHEREAS, 22q11.2 deletion syndrome can affect almost every
system in the body and cause a wide range of health problems;
and
WHEREAS, Given the limited scientific studies of this
syndrome, it is difficult to know how severely a child will be
affected; and
WHEREAS, Symptoms of the disorder do not consistently appear
to be related to the amount of genetic material lost in the
chromosomal deletion, and therefore, there may be a great deal
of variation in symptoms among affected individuals; and
WHEREAS, Common symptoms of the syndrome include heart
abnormalities, distinctive facial features, recurrent infections
due to a weakened immune system, gastrointestinal issues and
kidney problems; and
WHEREAS, Many children will also experience developmental
delays, delayed growth and speech and learning disabilities; and
WHEREAS, While not all symptoms associated with 22q11.2
deletion syndrome are life-threatening, many children and adults
affected by the deletion have numerous medical problems during
their lifetime that may require specialized care; and
WHEREAS, Although there is no cure for 22q11.2 deletion
syndrome, there are many therapies and medical interventions
available to treat the symptoms, and, the earlier that the
symptoms are detected, the more that doctors can do to help; and
WHEREAS, Clinical variability, lack of knowledge and the
20190HR0262PN1547 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30